Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol via EPIC vs Concept 1 in Asthma
NCT01845623Phase 2Withdrawn
- Sponsor
- Novartis
- Start
- Aug 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of indacaterol in asthma, sponsored by Novartis. Planned start Aug 2013; status: withdrawn.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01845623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845623.